Real-world study shows long-term safety, efficacy of Iluvien in DME

Real-world long-term study outcomes showed sustained safety and efficacy of Iluvien in patients with diabetic macular edema.
“The data also showed that IOP and VA outcomes were very similar to those reported in the pivotal FAME trials. It should be noted that real-world studies, particularly in the treatment of DME, very rarely confirmed the good outcomes of randomized clinical trials,” Ramin Khoramnia, MD, said at the virtual Association for Research in Vision and Ophthalmology meeting.
The Iluvien Registry Safety Study is an ongoing open-label observational study, recruiting

Full Story →